CARS2 and colitis: Indeed, CD4+ T cells with reduced levels of CARS2/CPERS exhibited accelerated cell cycle entry and induced severer colitis in Rag2-/- mice, and treatment with GSSSG, an endogenous donor of supersulfide that is generated by CARS2/CPERS, ameliorated inflammation.